Soluble cMet levels in urine are a significant prognostic biomarker for diabetic nephropathy-Reference-Cited by-同舟云学术

Soluble cMet levels in urine are a significant prognostic biomarker for diabetic nephropathy

Published:2018-08-24 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Kim Yong Chul,An Jung Nam,Kim Jin Hyuk,Choi Young-Wook,Oh Sohee,Kwon Sang Ho,Lee Mi-Young,Lee Junghun,Jeong Jae-Gyun,Lim Chun Soo,Kim Yon Su,Yang Seung Hee,Lee Jung Pyo^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-31121-1.pdf

Reference42 articles.

1. Groop, P. H. et al. The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Diabetes 58, 1651–1658 (2009).

2. Niewczas, M. A. et al. Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. J Am Soc Nephrol 23, 507–515 (2012).

3. Forsblom, C. et al. Added value of soluble tumor necrosis factor-alpha receptor 1 as a biomarker of ESRD risk in patients with type 1 diabetes. Diabetes Care 37, 2334–2342 (2014).

4. Krolewski, A. S. et al. Serum concentration of cystatin C and risk of end-stage renal disease in diabetes. Diabetes Care 35, 2311–2316 (2012).

5. Yeung, D. C. et al. Circulating levels of adipocyte and epidermal fatty acid-binding proteins in relation to nephropathy staging and macrovascular complications in type 2 diabetic patients. Diabetes Care 32, 132–134 (2009).

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Periostin deficiency attenuates kidney fibrosis in diabetic nephropathy by improving pancreatic β-cell dysfunction and reducing kidney EMT;Scientific Reports;2023-10-16

2. Renoprotective Effect of KLF2 on Glomerular Endothelial Dysfunction in Hypertensive Nephropathy;Cells;2022-02-22

3. Pathogenesis: Structural Changes in the Kidneys in Type 1 and Type 2 Diabetes;Diabetes and Kidney Disease;2022

4. Hepatocyte growth factor and soluble cMet levels in plasma are prognostic biomarkers of mortality in patients with severe acute kidney injury;Kidney Research and Clinical Practice;2021-12-31

5. cMet agonistic antibody prevents acute kidney injury to chronic kidney disease transition by suppressing Smurf1 and activating Smad7;Clinical Science;2021-06